Establishment of the Foot-and-Mouth Disease Virus Type Asia1 Expressing the HiBiT Protein: A Useful Tool for a NanoBiT Split Luciferase Assay

Giyoun Cho,Hyejin Kim,Dong-Wan Kim,Seong Yun Hwang,Ji-Hyeon Hwang,Yeon Rae Chae,Yoon-Hee Lee,Ok-Mi Jeong,Jung-Won Park,Sung-Han Park,Jong-Hyeon Park

DOI: https://doi.org/10.3390/v16071002

2024-06-22

Viruses

Abstract:Foot-and-mouth disease virus (FMDV) is a highly contagious virus that affects cloven-hoofed animals and causes severe economic losses in the livestock industry. Given that this high-risk pathogen has to be handled in a biosafety level (BSL)-3 facility for safety reasons and the limited availability of BSL-3 laboratories, experiments on FMDV call for more attention. Therefore, we aimed to develop an FMDV experimental model that can be handled in BSL-2 laboratories. The NanoBiT luciferase (Nano-luc) assay is a well-known assay for studying protein–protein interactions. To apply the NanoBiT split luciferase assay to the diagnosis and evaluation of FMD, we developed an inactivated HiBiT-tagged Asia1 Shamir FMDV (AS-HiBiT), a recombinant Asia1 shamir FMDV with HiBiT attached to the VP1 region of Asia1 shamir FMDV. In addition, we established LgBiT-expressing LF-BK cell lines, termed LgBit-LF-BK cells. It was confirmed that inactivated AS-HiBiT infected LgBiT-LF-BK cells and produced a luminescence signal by binding to the intracellular LgBiT of LgBiT-LF-BK cells. In addition, the luminescence signal became stronger as the number of LgBiT-LF-BK cells increased or the concentration of inactivated AS-HiBiT increased. Moreover, we confirmed that inactivated AS-HiBiT can detect seroconversion in sera positive for FMDV-neutralizing antibodies. This NanoBiT split luciferase assay system can be used for the diagnosis and evaluation of FMD and expanded to FMD-like virus models to facilitate the evaluation of FMDV vaccines and antibodies.

virology

What problem does this paper attempt to address?

The problems that this paper attempts to solve are several key challenges in foot - and - mouth disease virus (FMDV) research and diagnosis: 1. **Safety of handling high - risk pathogens**: Since FMDV is a highly contagious virus, it must be handled in a biosafety level 3 (BSL - 3) facility, which limits the wide - spread conduct of experiments. Therefore, researchers have developed an experimental model that can be handled in a BSL - 2 laboratory to improve the feasibility and safety of research. 2. **New methods for virus detection and evaluation**: Traditional methods such as the virus neutralization test (VNT) need to be carried out in BSL - 3 facilities, and the results are greatly influenced by the operator. To overcome these limitations, researchers have developed a new detection method using the NanoBiT split luciferase technology. This method can not only be carried out in a BSL - 2 laboratory, but also can provide faster and more consistent results. 3. **Evaluation of vaccines and antibodies**: By developing a recombinant FMDV expressing HiBiT protein (AS - HiBiT) and a cell line stably expressing LgBiT protein (LgBiT - LF - BK), researchers are able to evaluate the efficacy of FMDV vaccines and antibodies in a safer environment. 4. **Monitoring of virus entry into cells**: Using the complementary effect between HiBiT and LgBiT, researchers are able to monitor the process of virus entry into cells through the change of fluorescence signals, thereby better understanding the infection mechanism of the virus. In summary, the main purpose of this paper is to improve the safety and efficiency of FMDV research by developing a new detection system based on the NanoBiT split luciferase technology, and at the same time provide a faster and more reliable tool for the evaluation of vaccines and antibodies.

Establishment of the Foot-and-Mouth Disease Virus Type Asia1 Expressing the HiBiT Protein: A Useful Tool for a NanoBiT Split Luciferase Assay

Detection of Foot-and-mouth Virus Antibodies Using a Purified Protein from the High-Level Expression of Codon-Optimized, Foot-and-mouth Disease Virus Complex Epitopes in Escherichia Coli.

Implication of Broadly Neutralizing Bovine Monoclonal Antibodies in the Development of an Enzyme-Linked Immunosorbent Assay for Detecting Neutralizing Antibodies against Foot-and-mouth Disease Virus Serotype O.

Generation and characterisation of recombinant FMDV antibodies: Applications for advancing diagnostic and laboratory assays

Determination of Optimal Antigen Yield and Virus Inactivation Conditions for the Production of the Candidate Foot-and-Mouth Disease Recombinant Vaccine Strain Asia1 Shamir-R in a Bioreactor

Detection of foot-and-mouth disease virus RNA using a closed loop-mediated isothermal amplification system

Development of an Indirect ELISA Based on VP1-CRT Fusion Protein for Detection of FMDV-O in Swine

Evaluation of Foot-and-Mouth Disease (FMD) Virus Asia1 Genotype-V as an FMD Vaccine Candidate: Study on Vaccine Antigen Production Yield and Inactivation Kinetics

Development of HiBiT-Tagged Recombinant Infectious Bronchitis Coronavirus for Efficient in vitro and in vivo Viral Quantification

Recombinant vesicular stomatitis virus glycoprotein carrying a foot-and-mouth disease virus epitope as a vaccine candidate

A species-independent indirect-ELISA for detection of antibodies to the non-structural protein 2B of foot-and-mouth disease virus

A comprehensive and single-use foot-and-mouth disease sero-surveillance prototype employing rationally designed multiple viral antigens

Discovery, recognized antigenic structures, and evolution of cross-serotype broadly neutralizing antibodies from porcine B-cell repertoires against foot-and-mouth disease virus

[Establishment of colloidal gold-immunochromatography assay strip for detection of type Asia1 foot-and-mouth disease virus]

Development and Validation of a Competitive ELISA Based on Bovine Monoclonal Antibodies for the Detection of Neutralizing Antibodies against Foot-and-Mouth Disease Virus Serotype A.

Avidity of Polyclonal Antibodies to Foot-and-Mouth Disease Virus in Bovine Serum Measured Using Bio-Layer Interferometry

The Application of the Gibson Assembly Method in the Production of Two pKLS3 Vector-Derived Infectious Clones of Foot-and-Mouth Disease Virus

Indirect ELISA Using a Multi-Epitope Recombinant Protein to Detect Antibodies Against Foot-and-mouth Disease Virus Serotype O in Pigs.

Diagnostic and prophylactic potential of a stabilized foot-and-mouth disease serotype Asia1 virus like particles designed through a structure guided approach

Evaluation of a Vaccine Candidate Designed for Broad-Spectrum Protection against Type A Foot-and-Mouth Disease in Asia

The High Immunity Induced by the Virus-Like Particles of Foot-and-Mouth Disease Virus Serotype O